Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer.

The appropriate therapeutic strategy including preoperative treatment and resection should be cautiously considered preoperatively in patients with clinical N0 NSCLC who have large tumors and positive programmed death ligand-1 expression.